A CD4 cell defect could favor COPD through bronchial colonization especially by pneumocystis jiroveci and secondary bronchial inflammation, dysimmune processes and accelerated aging [39–42]. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.